Clinical Trial Update: Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on Leuprorelin acetate DPS (Leuplin DPS) for monthly/quarterly treatment in central precocious puberty has completed recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Leuprorelin acetate DPS (Leuplin DPS) (Leuprorelin acetate)

Snippet

Sponsor: Jin Soon Hwang | Conditions: Central Precocious Puberty | Phase 4 | Status: COMPLETED